Benzinga | Oct 27, 2020 07:09AM EDT

Exact Sciences Q3 EPS $(1.46) Misses $(0.52) Estimate, Sales $408.40M Beat $337.37M Estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(0.52) by 180.77 percent. This is a 370.97 percent decrease over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $408.40 million which beat the analyst consensus estimate of $337.37 million by 21.05 percent. This is a 86.65 percent increase over sales of $218.81 million the same period last year.